About
Drug Exporter
Areas of Focus
Categories
Generic DrugArgentinaSouth America
Clinical Trials (24)
View allTotal Trials
24
As Lead Sponsor
17
As Collaborator
7
Total Enrollment
6,778
By Phase
PHASE2: 7PHASE3: 6PHASE4: 4PHASE1: 5PHASE2/PHASE3: 1
By Status
COMPLETED: 17RECRUITING: 3UNKNOWN: 3TERMINATED: 1
Clinical Trials Pipeline24 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06629389Lead Sponsor
Clinical Trial with Cannabidiol (Kanbis®) for Parkinson Disease Symptoms
PHASE2Recruiting
88 participants
Started: Nov 28, 2024 · Completed: Nov 30, 2026
NCT05668650Lead Sponsor
Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLC
PHASE3Recruiting
174 participants
Started: Aug 15, 2023 · Completed: Dec 31, 2024
NCT04897516Lead Sponsor
Shorter Benznidazole Regimens Compared to the Standard Regimen for Chagas Disease
PHASE3Recruiting
300 participants
Started: Jul 28, 2021 · Completed: Dec 1, 2026
NCT04954235Collaborator
Effectiveness and Safety Study of Specific Hyperimmune Equine Serum for the Treatment of Severe Hospitalized SARS-CoV-2 in Adults: Retrospective Cohort Study
N/ACompleted
847 participants
Started: May 22, 2021 · Completed: Sep 9, 2021
NCT04560881Lead Sponsor
Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)
PHASE3Completed
3,000 participants
Started: Sep 16, 2020 · Completed: Dec 13, 2021
Locations (1)
Headquarters
Buenos Aires, Argentina
Map
Loading map...